ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 027,36
0,38%
Dow Jones
38 852,27
0,46%
DAX
18 293,51
0,67%
Brent Oil
82,965
-0,61%
Bitcoin
64 007,48
1,33%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Astrazeneca Plc (AZN)

  7. Astrazeneca Plc (AZN) Actualités

AZN

Astrazeneca (AZN)

Astrazeneca Plc
De:
Trier par:
 Showing the most relevant articles for your search:LSE:AZN
DateHeureSourceTitreSymboleSociété
07/05/202408h00RNS Regulatory NewsAstraZeneca PLC AstraZeneca completes Cellectis equity investmentLSE:AZNAstrazeneca Plc
06/05/202408h46Alliance NewsAlliance NewsAstraZeneca completes collaboration and investment deal with CellectisLSE:AZNAstrazeneca Plc
02/05/202411h04Alliance NewsAlliance NewsAstraZeneca notes positive trial results for Calquence treatmentLSE:AZNAstrazeneca Plc
02/05/202408h00RNS Regulatory NewsAstraZeneca PLC Calquence combination improved PFS in 1L MCLLSE:AZNAstrazeneca Plc
01/05/202416h00RNS Regulatory NewsAstraZeneca PLC Total Voting RightsLSE:AZNAstrazeneca Plc
29/04/202410h13Alliance NewsAlliance NewsAstraZeneca makes progress with Truqap and Enhertu cancer treatmentsLSE:AZNAstrazeneca Plc
29/04/202408h05RNS Regulatory NewsAstraZeneca PLC Truqap recommended for EU breast cancer approvalLSE:AZNAstrazeneca Plc
29/04/202408h00RNS Regulatory NewsAstraZeneca PLC Enhertu improved PFS in HER2-low and ultralowLSE:AZNAstrazeneca Plc
25/04/202414h00PR Newswire (US)AbelZeta Announces Abstract for C-CAR031 Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingLSE:AZNAstrazeneca Plc
25/04/202410h18Alliance NewsAlliance NewsTOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growthLSE:AZNAstrazeneca Plc
25/04/202408h00RNS Regulatory NewsAstraZeneca PLC 1st Quarter ResultsLSE:AZNAstrazeneca Plc
24/04/202411h32Alliance NewsAlliance NewsAngle shares jump on supplier agreement with with AstraZenecaLSE:AZNAstrazeneca Plc
16/04/202412h38Alliance NewsAlliance NewsIN THE KNOW: Deutsche ups AstraZeneca as higher payout addresses worryLSE:AZNAstrazeneca Plc
16/04/202409h39Alliance NewsAlliance NewsAstraZeneca's hails Imfinzi survival data on cancer formLSE:AZNAstrazeneca Plc
11/04/202418h42Alliance NewsAlliance News*AstraZeneca AGM resolutions pass, but 36% vote against remuneration policyLSE:AZNAstrazeneca Plc
11/04/202418h30RNS Regulatory NewsAstraZeneca PLC Result of AGMLSE:AZNAstrazeneca Plc
11/04/202409h56Alliance NewsAlliance NewsTOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023LSE:AZNAstrazeneca Plc
11/04/202408h00RNS Regulatory NewsAstraZeneca PLC AstraZeneca increases 2024 dividend by 7%LSE:AZNAstrazeneca Plc
08/04/202409h36Alliance NewsAlliance NewsTOP NEWS: AstraZeneca hails neurological data for Ultomiris, SolirisLSE:AZNAstrazeneca Plc
08/04/202408h00RNS Regulatory NewsAstraZeneca PLC Enhertu approved in US for HER2+ solid tumoursLSE:AZNAstrazeneca Plc
08/04/202407h53Alliance NewsAlliance NewsTOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approvalLSE:AZNAstrazeneca Plc
05/04/202410h42Alliance NewsAlliance NewsAstraZeneca makes "breakthrough" in treating small cell lung cancerLSE:AZNAstrazeneca Plc
05/04/202408h00RNS Regulatory NewsAstraZeneca PLC Imfinzi improved OS & PFS in limited-stage SCLCLSE:AZNAstrazeneca Plc
03/04/202412h02Alliance NewsAlliance NewsCORRECT: AstraZeneca, Daiichi make US progress with licence approvalsLSE:AZNAstrazeneca Plc
02/04/202411h25Alliance NewsAlliance NewsAstraZeneca and Daiichi make US progress with latest licence approvalsLSE:AZNAstrazeneca Plc
02/04/202408h05RNS Regulatory NewsAstraZeneca PLC Voydeya approved in USLSE:AZNAstrazeneca Plc
02/04/202408h00RNS Regulatory NewsAstraZeneca PLC FDA accepts Dato-DXd BLA for breast cancerLSE:AZNAstrazeneca Plc
27/03/202410h19Alliance NewsAlliance NewsAstraZeneca treatments become "first and only" to be approved in JapanLSE:AZNAstrazeneca Plc
25/03/202409h40Alliance NewsAlliance NewsTOP NEWS: AstraZeneca wins US approval for rare nervous system diseaseLSE:AZNAstrazeneca Plc
25/03/202408h00RNS Regulatory NewsAstraZeneca PLC Ultomiris approved in the US for NMOSDLSE:AZNAstrazeneca Plc
 Showing the most relevant articles for your search:LSE:AZN

Dernières Valeurs Consultées

EU
RNO
Renault
NYSE
MRK
Merck
EU
RI
Pernod Ricard
NYSE
JPM
JP Morgan Chase
EU
PX4
SBF 120
EU
VK
Vallourec
EU
BN
Danone
USI
USTECH100
US Tech 100
NYSE
KO
Coca Cola
EU
DG
Vinci
EU
AF
Air FranceKLM
EU
HO
Thales
NASDAQ
GOOGL
Alphabet
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés